2月12日，ST联创（维权）公告，公司拟以集中竞价交易方式回购股份。回购价格不超3.26元/股。资金 来源为自有资金。 ST联创当前最新价为6.29元，今年以来，ST联创股价累计上涨4.31%。此次公告拟定的最高回购价格， 比现价低48.17%。 股票回购往往被视为一种稳价措施。指上市公司用现金等方式从股票市场买回自家公司已经发行在外的 一定数额的股票。一般来讲，回购后可以注销，也可以用于实施员工持股计划或股权激励计划等。 资料显示，山东联创产业发展集团股份有限公司位于山东省淄博市张店区华光路366号科创大厦B座9 层，成立日期2003年1月29日，上市日期2012年8月1日，公司主营业务涉及聚氨酯硬泡组合聚醚的技术 研发、生产与销售,互联网广告营销业务。主营业务收入构成为：含氟新材料73.60%，聚氨酯新材料 25.86%，其他0.54%。 分红方面，ST联创A股上市后累计派现2.04亿元。近三年，累计派现0.00元。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@s ...

Core Viewpoint - The stock of Hebang Biotechnology has shown significant price increases recently, with a year-to-date rise of 17.70% and a 19.82% increase over the past five trading days, indicating strong market interest despite a decline in revenue and profit [1][2]. Company Overview - Hebang Biotechnology, established on August 1, 2002, and listed on July 31, 2012, is located in Leshan, Sichuan Province. The company specializes in the manufacturing of pesticides and intermediates, fine chemicals, intelligent glass, special glass, and the development of soda ash, ammonium chloride, and mineral resources [1]. - The company's revenue composition includes 85.89% from chemical products, 17.61% from photovoltaic glass and other products, 6.74% from mineral products, and 5.02% from other businesses [1]. Financial Performance - For the period from January to September 2025, Hebang Biotechnology reported a revenue of 5.927 billion yuan, a year-on-year decrease of 13.02%. The net profit attributable to shareholders was 93.1085 million yuan, down 57.93% compared to the previous year [2]. - The company has distributed a total of 1.205 billion yuan in dividends since its A-share listing, with 553 million yuan distributed over the past three years [3]. Shareholder Structure - As of September 30, 2025, the number of shareholders for Hebang Biotechnology was 196,500, a decrease of 1.99% from the previous period. The average number of circulating shares per person increased by 2.03% to 44,939 shares [2]. - Among the top ten circulating shareholders, notable changes include the entry of new shareholders such as Penghua Zhongzheng Segmented Chemical Industry Theme ETF and the increase in holdings by Hong Kong Central Clearing Limited [3].

Group 1: Stock Performance - As of January 23, Huayi Group's stock price increased by 2.10%, reaching 9.73 CNY per share, with a trading volume of 218 million CNY and a turnover rate of 1.22%, resulting in a total market capitalization of 20.655 billion CNY [1] - Year-to-date, Huayi Group's stock price has risen by 26.20%, with an 8.72% increase over the last five trading days, a 31.13% increase over the last 20 days, and a 22.24% increase over the last 60 days [1] Group 2: Financial Performance - For the period from January to September 2025, Huayi Group achieved a revenue of 35.708 billion CNY, representing a year-on-year growth of 4.68%, while the net profit attributable to shareholders decreased by 34.50% to 395 million CNY [3] - The company has distributed a total of 4.298 billion CNY in dividends since its A-share listing, with 1.064 billion CNY distributed over the past three years [4] Group 3: Shareholder Information - As of September 30, 2025, Huayi Group had 55,200 shareholders, a decrease of 4.81% from the previous period, with an average of 0 circulating shares per shareholder [3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 13.8265 million shares, an increase of 3.1768 million shares from the previous period, while the Southern CSI 1000 ETF has exited the top ten list [4] Group 4: Business Overview - Huayi Group, established on August 5, 1992, and listed on December 4, 1992, is located in Shanghai and primarily engages in the research, production, and sales of tires, energy chemicals, fine chemicals, and chemical services [2] - The main business revenue composition includes fine chemicals (19.84%), tire manufacturing (12.51%), and various segments of energy chemicals and chemical services [2]

Core Viewpoint - Huayi Group's stock has shown significant growth in recent trading sessions, with a year-to-date increase of 22.70% and a notable rise of 15.51% over the past five trading days [1] Company Overview - Shanghai Huayi Group Co., Ltd. was established on August 5, 1992, and listed on December 4, 1992. The company is primarily engaged in the research, production, and sales of tires, energy chemicals, fine chemicals, and chemical services [2] - The revenue composition of Huayi Group includes: fine chemicals (19.84%), tire manufacturing (12.51%), energy chemicals (8.71%), and chemical services (6.50%) among others [2] Financial Performance - As of September 30, Huayi Group reported a total revenue of 35.708 billion yuan for the period from January to September 2025, reflecting a year-on-year growth of 4.68%. However, the net profit attributable to shareholders decreased by 34.50% to 395 million yuan [3] - The company has distributed a total of 4.298 billion yuan in dividends since its A-share listing, with 1.064 billion yuan distributed over the past three years [4] Shareholder Information - As of September 30, 2025, Huayi Group had 55,200 shareholders, a decrease of 4.81% from the previous period. The average circulating shares per person remained at 0 [3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 13.8265 million shares, an increase of 3.1768 million shares from the previous period [4]